C
우진비앤지
018620KOSDAQ52.0 / 100
Reference Date: 2026-10-23
Financial Score19.5 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Roughly flat over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Ujin B&G is a specialized company in animal pharmaceuticals, producing medications, vaccines, and supplements, with 35% of its sales coming from exports. Its subsidiaries, OSPI and Bawow Korea, manufacture pet food and treats, and the company aims to expand its market share through eco-friendly products and vaccine development.
Number of Employees
103people
Average Salary
54.2M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
0.30Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
-5.38Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
24.70Industry Average 100.008.0Point
Half of industry avg (excellent)
Trend 2023~20250.5 / 10 points
Revenue Growth Rate
0.5 / 3
Avg ▼2.8% (2-year basis)
Operating Profit Growth Rate
0.0 / 3
Avg ▼25.3% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -4.2% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position6.0Point
52w upper range (76%)
Current 2,750Won52-week high 3,40052-week low 670
1-month return3.0Point
1m -0.72% (flat)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
2 totalPositive 0Neutral 2Negative 0
- Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-09-30
- Neutral주식등의대량보유상황보고서(일반)2026-09-30